Bristol Myers Squibb secures FDA nod for Breyanzi in marginal zone lymphoma
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
Valorum will advance the commercialization and distribution of Armlupeg in the United States
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Siponimod Tablets is indicated for the treatment of relapsing forms of multiple sclerosis
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Growing patent filings and tier-2 innovators reflect expanding national research base
Subscribe To Our Newsletter & Stay Updated